Society of Toxicology 2026 Annual Meeting and ToxExpo

HESI Global committees will be attending the SOT 65th Annual Meeting and ToxExpo.

Connect with them at the sessions below:

Sunday, 22 March

• Continuing Education (CE) Course
  Immuno-Safety Technical Committee
  Lost in Translation? Navigating Species Selection for Immunotoxicological Assessment in Preclinical Studies

Monday, 23 March

• 1:45 PM PT – Poster
  Botanical Safety Consortium
  Assessing Human Hepatotoxicity from Botanicals: A Multi-Tiered In Silico Screening Approach – presented by Chao Ji, CDC
• 1:45 – 4:15 PM PT – Poster
  Developmental and Reproductive Toxicology (DART)
  Ontogeny of placental FcRn protein during human and animal pregnancy to inform developmental toxicity testing
• 2:00 – 4:45 PM PT – Symposium
  Emerging Systems Toxicology for the Assessment of Risk (eSTAR)
  AI in Toxicology: Navigating Promise, Pitfalls, and Practical Implementation
• 2:00 – 4:45 PM PT – Symposium
  Immuno-Safety Technical Committee
  Rebuilding Immunity in the Lab: Complex NAMs for Smarter Safety Science – Chaired by Mark Collinge (Pfizer) and Chrissy Crute (HESI Global)

Tuesday, 24 March

• 9:15 AM PT – Presentation
  Botanical Safety Consortium
  Evaluating the hepatotoxic potential of Green Tea and Kava Root Extract in primary human hepatocytes – presented by Kirsten Eckstrum, FDA
• 9:15 AM PT – Poster
  Targeted Protein Degrader Safety
  Preclinical Safety Assessment of Targeted Protein Degraders: Current Practices and Considerations - presented by Alanna Sedgwick
• 1:00 – 1:15 PM PT – Session: Sowing the Seeds of Safety
  Botanical Safety Consortium
  Advancing Dermal Toxicity Assessment for Botanicals: in silico approaches – presented by Argel Islas-Robles, IIVS
  Integration of computational models to predict botanical phytochemical constituent clearance routes by the ECCS – presented by Yitong Liu, FDA
• 1:45 PM PT – Posters
  Botanical Safety Consortium
  From neat compounds to complex mixtures: Microphysiological systems for cardiotoxicity safety testing of botanical extracts – presented by Matthias Gossmann, innoVitro
  Assessing the neurotoxic and cardiotoxic potential of botanical extracts using microelectrode array (MEA) recordings – presented by Remco Westerink, Utrecht University
• 1:45 PM PT – Poster
  Emerging Systems Toxicology for the Assessment of Risk (eSTAR)
  Divergent Estrogen Receptor Alpha (ERα) Activation Distinguishes Hepatic Responses to Diethylstilbestrol and 17ß-Estradiol – presented by Kati Venneman, KUMC
• 4:30 – 6:00 PM PT – Symposium
  Emerging Systems Toxicology for the Assessment of Risk (eSTAR) & Developmental and Reproductive Toxicology (DART)
  Toward a New Paradigm: Can Mechanistic In Vivo Studies Replace Traditional DART Guideline Studies?

Wednesday, 25 March

• 9:15 AM PT – Poster
  Targeted Protein Degrader Safety
  Pharmaceutical Safety Considerations for Cereblon-Recruiting Targeted Protein Degraders - presented by Ruth Roberts
• 1:45 PM PT – Poster
  Emerging Systems Toxicology for the Assessment of Risk (eSTAR)
  Identification of transcriptional biomarkers for major molecular initiating events in rat liver carcinogenesis – presented by Kati Venneman, Kansas University Medical Center